NCT03016819
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03016819
Title Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) (APROMISS)
Acronym APROMISS
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Advenchen Laboratories, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP

Facility Status City State Zip Country Details
Mayo Clinic Arizona COMPLETED Phoenix Arizona 85054 United States Details
University of California Los Angeles COMPLETED Los Angeles California 90404 United States Details
Sarcoma Oncology Center RECRUITING Santa Monica California 90403 United States Details
Stanford Medicine Cancer Institute COMPLETED Stanford California 94305 United States Details
University of Colorado Denver COMPLETED Aurora Colorado 80045 United States Details
Mayo Clinic Jacksonville COMPLETED Jacksonville Florida 32224 United States Details
University of Miami Sylvester Comprehensive Cancer Center COMPLETED Miami Florida 33136 United States Details
Northwestern University COMPLETED Chicago Illinois 60611 United States Details
University of Michigan Comprehensive Cancer Center COMPLETED Ann Arbor Michigan 48109 United States Details
Mayo Clinic Rochester COMPLETED Rochester Minnesota 55905 United States Details
Washington University St. Louis COMPLETED St Louis Missouri 63130 United States Details
Columbia University Medical Center WITHDRAWN New York New York 10032 United States Details
Thomas Jefferson Hospital - Sidney Kimmel Cancer Center COMPLETED Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Medical Center COMPLETED Pittsburgh Pennsylvania 15219 United States Details
Vanderbilt University COMPLETED Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center COMPLETED Houston Texas 77030 United States Details
UW Medicine-Seattle Cancer Care Alliance COMPLETED Seattle Washington 98109 United States Details
Beijing Cancer Hospital COMPLETED Beijing China Details
Shanghai Sixth People's Hospital COMPLETED Shanghai China Details
Istituto Nazionale dei Tumori COMPLETED Milan Italy Details
University of Palermo COMPLETED Palermo Italy Details
University Campus Bio-Medico COMPLETED Rome Italy Details
Hospital de la Santa Creu i Sant Pau COMPLETED Barcelona Spain Details
Royal Marsden Hospital NOT_YET_RECRUITING London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field